Develops antibody therapies targeting multiple disease pathways to improve treatment efficacy in ophthalmic diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Ollin Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative therapies for vision-threatening ophthalmic diseases. The company is advancing a pipeline of bispecific antibody candidates designed to target multiple disease pathways simultaneously, aiming to improve treatment efficacy and patient outcomes. With a commitment to addressing unmet medical needs, Ollin Biosciences is dedicated to redefining the standard of care in ophthalmology.
Ollin Biosciences Funding
Sign up to gain insights into Ollin Biosciences funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series A | Sep 17, 2025 | 100M | ||
| Series A | Jul 12, 2024 | 14M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Ollin Biosciences Management Team
Investors
ARCH Venture Partners
Monograph Capital
Mubadala Capital
Ollin Biosciences Valuations & Financials
View real-time NPM data on Ollin Biosciences stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Similar Companies
like Ollin Biosciences
Cerebral
Health Care
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Virta Health
Health Care
Online specialty medical clinic focused on reversing type 2 diabetes.
Color Genomics
Health Care
Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.
Somatus
Health Care
Integrated care for patients with or at risk of developing kidney disease.
Curology
Health Care
Offers personalized prescription skin care medications delivered directly to you.
Eikon Therapeutics
Health Care
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Benchling
Health Care
Cloud based platform for research and development in biotechnology.
FAQ
We have answers
Ollin Biosciences stock does not trade on public stock exchanges. Ollin Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Ollin Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Ollin Biosciences Stock does not trade on public stock exchanges. In order to sell Ollin Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Ollin Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Ollin Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Ollin Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Ollin Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Ollin Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Ollin Biosciences is a private company and has not had an IPO. There is currently no Ollin Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Ollin Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
